Table 1.
Demographic characteristics of patients
| Demographic characteristic | Group A (n = 31)a | Group B (n = 30)a | t value | P value |
|---|---|---|---|---|
| Age (years) | 35.87 ± 9.10 | 37.87 ± 10.10 | − 0.811 | 0.420 |
| Height (cm) | 161.68 ± 5.26 | 159.53 ± 4.95 | 1.640 | 0.106 |
| Weight (kg) | 56.66 ± 6.35 | 53.92 ± 5.58 | 1.791 | 0.078 |
| Body mass ndex | 21.66 ± 1.80 | 21.11 ± 1.67 | 1.241 | 0.220 |
Data are presented as the mean ± standard deviation.(SD). No significant differences were found between the two groups with respect to these characteristics
aPatients were administered 0.1 μg/kg nalbuphine (group A) or 0.2 μg/kg nalbuphine (group B) intravenously 3 min before endoscopic placement